NCT02523040 2025-12-10Lenalidomide for Adult Histiocyte DisordersDana-Farber Cancer InstitutePhase 2 Active not recruiting12 enrolled 14 charts
NCT04198818 2024-07-19A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced TumorsHaihe Biopharma Co., Ltd.Phase 1/2 Terminated37 enrolled 30 charts